Solesence Q2 revenue falls on prior-year product launch boost - SLSN News | RalliesSolesence Q2 revenue falls on prior-year product launch boost
S
SLSN• Outlook
- Company did not provide specific financial guidance or outlook for future periods
Overview
- US skin health solutions provider's Q2 revenue fell yr/yr due to prior-year product launch boost
- Company posted Q2 net loss, reversing net income from prior year
- Company completed review of historical inventory costing allocation methodologies
Key details
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|
| Q2 Revenue | | $15.33 mln | |
| Q2 Gross Profit | | $4.75 mln | |
| Q2 Pretax Loss | | $158,000 | |
Result drivers
- Prior-year launch boost - Co said Q2 2025 revenue benefited from a one-time product launch and inventory pipeline fill
- Operational efficiency initiatives - Co said it focused on operational execution and targeted efficiency initiatives in Q2
- Higher SG&A - Selling, general and administrative expense rose to $3.7 mln from $3.0 mln yr/yr, contributing to the net loss
